RA
QIPT

Royce & Associates’s Quipt Home Medical QIPT Stock Holding History

Royce & Associates’s Portfolio QIPT Stock Details QIPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-781,829
Closed -$2.04M – 804
2025
Q3 		$2.04M Sell
781,829
-120,000
-13% -$277K 0.02% 589
2025
Q2 		$1.61M Sell
901,829
-1,048,160
-54% -$2.07M 0.02% 623
2025
Q1 		$4.54M Sell
1,949,989
-32,100
-2% -$88K 0.05% 459
2024
Q4 		$6.05M Buy
1,982,089
+213,300
+12% +$574K 0.06% 444
2024
Q3 		$5.16M Buy
1,768,789
+240,980
+16% +$744K 0.05% 472
2024
Q2 		$4.92M Buy
1,527,809
+306,626
+25% +$1.1M 0.05% 485
2024
Q1 		$5.34M Buy
1,221,183
+138,267
+13% +$625K 0.05% 483
2023
Q4 		$5.51M Buy
1,082,916
+89,400
+9% +$428K 0.05% 473
2023
Q3 		$5.06M Buy
993,516
+468,975
+89% +$2.51M 0.05% 471
2023
Q2 		$2.8M Buy
524,541
+53,706
+11% +$317K 0.03% 618
2023
Q1 		$3.3M Buy
+470,835
New +$2.9M 0.03% 579

Other funds holding QIPT

FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Royce & Associates's QIPT Position: Q4 2025 in Review

Royce & Associates sold out of Quipt Home Medical (QIPT) in Q4 2025, closing a stake of 781,829 shares — an estimated $2.04M sold.

Royce & Associates first reported a position in QIPT in Q1 2023 and held it in 11 quarters. The position peaked at $6.05M in Q4 2024. 70 funds tracked by Wall St. Rank hold QIPT as of Q4 2025.

  • Royce & Associates reported no remaining Quipt Home Medical position as of Q4 2025 after selling out during the quarter.
  • Royce & Associates sold 781,829 Quipt Home Medical shares in Q4 2025, an estimated $2.04M.
  • Royce & Associates first reported a position in Quipt Home Medical in Q1 2023 and held it in 11 quarters.
  • Royce & Associates's Quipt Home Medical position peaked at $6.05M in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Quipt Home Medical as of Q4 2025.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.